Filippo Ciceri

Title: Filippo Ciceri: Innovator in Hematological Treatments

Introduction

Filippo Ciceri is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of hematological malignancies. His innovative work has led to the development of a patent that showcases his expertise and dedication to improving patient outcomes.

Latest Patents

Ciceri holds a patent for "Combinations of LSD1 inhibitors for the treatment of hematological malignancies." This invention relates to combinations of the compound of formula (I) or pharmaceutically acceptable salts thereof with other active pharmaceutical ingredients. The pharmaceutical compositions comprising these combinations are designed for use as medicaments, specifically targeting hematological malignancies.

Career Highlights

Filippo Ciceri is associated with Oryzon Genomics S.A., a company that focuses on innovative solutions in the field of genomics and personalized medicine. His work at Oryzon has allowed him to explore new therapeutic avenues and contribute to groundbreaking research in hematological treatments.

Collaborations

Ciceri collaborates with talented professionals in his field, including Serena Lunardi and Tamara Maes. These partnerships enhance the research and development efforts at Oryzon Genomics, fostering an environment of innovation and discovery.

Conclusion

Filippo Ciceri's contributions to the field of hematological malignancies through his patent and work at Oryzon Genomics highlight his role as a key innovator in medicine. His dedication to advancing treatment options is commendable and reflects the importance of innovation in healthcare.